Quetiapine discontinuation syndrome.
Kim
Deborah R
DR
Staab
Jeffrey P
JP
D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000188:drug therapy; D003987:Dibenzothiazepines / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D009325:Nausea / Q000139:chemically induced / Q000188:drug therapy; D011346:Prochlorperazine / Q000627:therapeutic use; D000069348:Quetiapine Fumarate; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy / Q000209:etiology*; D016896:Treatment Outcome
D014150:Antipsychotic Agents; D003987:Dibenzothiazepines; D000069348:Quetiapine Fumarate; D011346:Prochlorperazine